CDEK by Data4ThePeople
Sign in Sign up
← All organizations

NeurogesX

For profitContributed to NME

Also known as: Neurogesx

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2002

First marketed drug

Nov 16, 2009

First NDA

Nov 16, 2009

Last known activity

Oct 1, 2010

Defunct as of Apr 17, 2013

Timeline

1990s

  1. Jul 1, 1998

    NeurogesX— Founded

2000s

  1. Nov 16, 2009

    capsaicin— NDA Organization

2010s

  1. Apr 17, 2013

    NeurogesX— Defunct

Drugs by trial phase (3 distinct, 17 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (27)

Details

Founded
San Carlos, CA, US Jul 1, 1998
First NDA
Nov 16, 2009
Last known activity
Oct 1, 2010

Designations held

  • Orphan drug